Lexology July 13, 2022
On July 6, 2022, Katherine Vidal, the Undersecretary of Commerce for Intellectual Property and Director of the USPTO, published her response to the letter sent by Janet Woodcock (former acting FDA Commissioner) to the former Director of the USPTO, Andrew Hirshfield. Concurrently, Director Vidal and Commissioner Califf published a blog post summarizing the steps the Biden Administration is taking to promote competition and lower drug prices. We previously posted on the original Woodcock letter.
As a reminder, the letter from Commissioner Woodcock was sent to Director Hirshfield pursuant to Executive Order 14036 (Executive Order on Promoting Competition in the American Economy | The White House), which focused on promoting competition in the American economy, including with respect to pharmaceuticals. With...